Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Classification of two steroids, prostanozol and methasterone, as Schedule III anabolic steroids under the Controlled Substance Act. Final rule.

Drug Enforcement Administration (DEA), Department of Justice..

Fed Regist. 2012 Jul 30;77(146):44456-62.

2.

Classification of three steroids as schedule III anabolic steroids under the Controlled Substances Act. Final rule.

Drug Enforcement Administration (DEA), Department of Justice..

Fed Regist. 2009 Dec 4;74(232):63603-10.

3.

Schedules of controlled substances: placement of tapentadol into schedule II. Final rule.

Drug Enforcement Administration, Department of Justice..

Fed Regist. 2009 May 21;74(97):23790-3.

4.

Schedules of controlled substances: placement of pregabalin into schedule V. Final rule.

Drug Enforcement Administration, Department of Justice..

Fed Regist. 2005 Jul 28;70(144):43633-5.

5.

Schedules of controlled substances: placement of 5-methoxy-N,N-dimethyltryptamine into Schedule I of the Controlled Substances Act. Final rule.

Drug Enforcement Administration (DEA), Department of Justice..

Fed Regist. 2010 Dec 20;75(243):79296-300.

6.

Schedules of controlled substances: temporary placement of three synthetic cathinones in Schedule I. Final Order.

Drug Enforcement Administration, Department of Justice..

Fed Regist. 2011 Oct 21;76(204):65371-5.

7.

Schedule of controlled substances: placement of dichloralphenazone into Schedule IV. Final rule.

Drug Enforcement Administration (DEA), Department of Justice..

Fed Regist. 2001 Aug 16;66(159):42943-4.

8.

Schedules of controlled substances: placement of lisdexamfetamine into schedule II. Final rule.

Drug Enforcement Administration, Department of Justice..

Fed Regist. 2007 May 3;72(85):24532-4.

9.

Schedules of controlled substances: placement of Zopiclone into schedule IV. Final rule.

Drug Enforcement Administration, Department of Justice..

Fed Regist. 2005 Apr 4;70(63):16935-7.

10.

Schedule of controlled substances; placement of fospropofol into schedule IV. Final rule.

Drug Enforcement Administration, Department of Justice..

Fed Regist. 2009 Oct 6;74(192):51234-6.

11.

Schedules of controlled substances: rescheduling of buprenorphine from schedule V to schedule III. Final rule.

Drug Enforcement Administration (DEA), Department of Justice..

Fed Regist. 2002 Oct 7;67(194):62354-70.

12.

Schedules of controlled substances: placement of ezogabine into Schedule V. Final rule.

Drug Enforcement Administration, Department of Justice..

Fed Regist. 2011 Dec 15;76(241):77895-99.

13.
14.

Schedules of controlled substances; exempt anabolic steroid products. Final rule.

Drug Enforcement Administration (DEA), Department of Justice..

Fed Regist. 2008 Mar 17;73(52):14178-9.

15.

Schedules of controlled substances: placement of lacosamide into schedule V. Final rule.

Drug Enforcement Administration (DEA), Department of Justice..

Fed Regist. 2009 May 21;74(97):23789-90.

16.
17.

Schedules of controlled substances: placement of perampanel into Schedule III. Final rule.

Drug Enforcement Administration, Department of Justice..

Fed Regist. 2013 Dec 2;78(231):72013-6.

18.
19.

Designation of oripavine as a basic class of controlled substance. Final rule.

Drug Enforcement Administration (DEA), Justice..

Fed Regist. 2007 Sep 24;72(184):54208-10.

20.

Schedules of controlled substances: removal of naloxegol from control. Final rule.

Drug Enforcement Administration, Department of Justice..

Fed Regist. 2015 Jan 23;80(15):3468-70.

Supplemental Content

Support Center